Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation.

about

Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation.

Item

http://www.wikidata.org/entity/Q46390290

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Donor lymphocyte infusion and ...... aploidentical transplantation.

@en

Donor lymphocyte infusion and ...... aploidentical transplantation.

@nl

type

Item

label

Donor lymphocyte infusion and ...... aploidentical transplantation.

@en

Donor lymphocyte infusion and ...... aploidentical transplantation.

@nl

prefLabel

Donor lymphocyte infusion and ...... aploidentical transplantation.

@en

Donor lymphocyte infusion and ...... aploidentical transplantation.

@nl

P1476

Donor lymphocyte infusion and ...... haploidentical transplantation

@en

P2093

Anastasia Ivanova

http://www.w3.org/2001/XMLSchema#string

Carrie Barnhart

http://www.w3.org/2001/XMLSchema#string

Krishna Shah

http://www.w3.org/2001/XMLSchema#string

Mark Cannon

http://www.w3.org/2001/XMLSchema#string

Michelle Hyland

http://www.w3.org/2001/XMLSchema#string

Morton J Cowan

http://www.w3.org/2001/XMLSchema#string

Stacy Epstein

http://www.w3.org/2001/XMLSchema#string

Tracy Fukes

http://www.w3.org/2001/XMLSchema#string

Wing Leung

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL.

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

One-unit versus two-unit cord-blood transplantation for hematologic cancers.

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.

Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies

Hematopoietic stem-cell transplantation.

P304

169-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.24949

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew L Gilman

P577

2017-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29047161

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte